We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

RBC Capital analyst Leonid Timashev reiterated a Buy rating on Legend Biotech (LEGN – Research Report) today and set a price target of $84.00.

GENEVA (AP) — Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

In a report released today, Gena Wang from Barclays maintained a Buy rating on Legend Biotech (LEGN – Research Report), with a price target of ...

The company's cancer cell therapy Carvykti, which it makes in partnership with Legend Biotech, brought in sales of $369 ...

According to InvestingPro data, leading companies in the sector like Legend Biotech maintain "GOOD" overall financial health scores despite market challenges. The biotech sector is deemed defensive as ...

The Legend Returns sees the Kiwi comedian, actor and star of such terrific screen hits as Hunt for the Wilder People, Flight of the Conchords and Our Flag Means Death is also a gifted stand-up ...